BSI Life Sciences announced the launch of BSI CTMS (Clinical Trial Management System) 7.0. The newest version of the eClinical platform includes 50+ enhancements and an optimized user interface, and represents a significant milestone in the company’s history. “After months of development and testing, we are excited that the wait is over, and the latest CTMS upgrade is now available for all our current and prospect customers,” said Jan Nielsen, BSI Life Sciences Community Manager. “What makes us most proud is that the product has been developed based on the feedback received from our end users, who largely consist of Clinical Research Associates and Trial Managers,” continues Nielsen. Among others, BSI’s just-released eClinical tool features a new Study Arms functionality to track allocated treatments, an option to configure clinical trial registries as well as enhanced Risk and Action Item management modules. Further, the integrated eTMF has been improved with additional features for better usability.

“BSI CTMS release 7.0 is a great achievement for our software house,” commented Markus Brunold, CEO of BSI. “We’re thrilled for the launch, plus this comes only few months after the announcement of our strategic partnership with Ledger Run, a leading provider of study start up and site payment solutions. Indeed, another success worth celebrating,” he remarked.

BSI CTMS 7.0 will be the start version for two newly onboarded BSI’s clients in North America and one in Europe, with more to come in summer 2023.

On Tuesday, June 13th, from 3 – 4 PM CEST (9 – 10 AM EST), BSI Life Sciences will host a free webinar to present the latest CTMS upgrade to clinical trial leaders, IT specialists and other interested attendees. Participants can confirm their attendance by registering at BSI CTMS 7.0 Release Webinar.